| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | zinc ion binding | 4.26e-05 | 891 | 39 | 9 | GO:0008270 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 5.28e-05 | 512 | 39 | 7 | GO:0019787 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 6.72e-05 | 532 | 39 | 7 | GO:0016755 | |
| GeneOntologyMolecularFunction | transition metal ion binding | CXXC5 RNF144B RNF151 KMT2A GRIN2A ZNF91 MDM2 ABCE1 DBF4 LTN1 | 7.01e-05 | 1189 | 39 | 10 | GO:0046914 |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 7.79e-05 | 372 | 39 | 6 | GO:0061630 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.13e-04 | 398 | 39 | 6 | GO:0061659 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 2.88e-04 | 473 | 39 | 6 | GO:0004842 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 3.77e-04 | 320 | 39 | 5 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 4.11e-04 | 326 | 39 | 5 | GO:0001217 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 6.71e-04 | 775 | 39 | 7 | GO:0016746 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 2.25e-03 | 36 | 39 | 2 | GO:0019789 | |
| GeneOntologyBiologicalProcess | regulation of brain-derived neurotrophic factor-activated receptor activity | 1.09e-11 | 4 | 39 | 4 | GO:0031551 | |
| GeneOntologyBiologicalProcess | negative regulation of brain-derived neurotrophic factor receptor signaling pathway | 5.45e-11 | 5 | 39 | 4 | GO:0031549 | |
| GeneOntologyBiologicalProcess | regulation of brain-derived neurotrophic factor receptor signaling pathway | 3.80e-10 | 7 | 39 | 4 | GO:0031548 | |
| GeneOntologyBiologicalProcess | brain-derived neurotrophic factor receptor signaling pathway | 1.08e-08 | 14 | 39 | 4 | GO:0031547 | |
| GeneOntologyBiologicalProcess | negative regulation of protein tyrosine kinase activity | 2.89e-07 | 30 | 39 | 4 | GO:0061099 | |
| GeneOntologyBiologicalProcess | negative regulation of signaling receptor activity | 4.29e-07 | 33 | 39 | 4 | GO:2000272 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-tyrosine phosphorylation | 4.61e-06 | 59 | 39 | 4 | GO:0050732 | |
| GeneOntologyBiologicalProcess | regulation of protein tyrosine kinase activity | 8.63e-06 | 69 | 39 | 4 | GO:0061097 | |
| GeneOntologyBiologicalProcess | traversing start control point of mitotic cell cycle | 3.47e-05 | 5 | 39 | 2 | GO:0007089 | |
| GeneOntologyBiologicalProcess | transposable element silencing | 8.97e-05 | 46 | 39 | 3 | GO:0010526 | |
| GeneOntologyBiologicalProcess | retrotransposition | 1.02e-04 | 48 | 39 | 3 | GO:0032197 | |
| GeneOntologyBiologicalProcess | regulation of signaling receptor activity | 1.08e-04 | 131 | 39 | 4 | GO:0010469 | |
| GeneOntologyBiologicalProcess | transposition | 1.15e-04 | 50 | 39 | 3 | GO:0032196 | |
| GeneOntologyBiologicalProcess | spontaneous neurotransmitter secretion | 2.27e-04 | 12 | 39 | 2 | GO:0061669 | |
| GeneOntologyBiologicalProcess | protein autoubiquitination | 4.31e-04 | 78 | 39 | 3 | GO:0051865 | |
| GeneOntologyBiologicalProcess | spontaneous synaptic transmission | 5.23e-04 | 18 | 39 | 2 | GO:0098814 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 6.99e-04 | 92 | 39 | 3 | GO:0051966 | |
| GeneOntologyBiologicalProcess | negative regulation of protein kinase activity | 7.86e-04 | 221 | 39 | 4 | GO:0006469 | |
| MousePheno | abnormal somatic hypermutation frequency | 6.53e-08 | 19 | 30 | 4 | MP:0004815 | |
| MousePheno | increased B cell apoptosis | 3.40e-07 | 28 | 30 | 4 | MP:0008782 | |
| MousePheno | increased germinal center B cell number | 5.21e-07 | 31 | 30 | 4 | MP:0008177 | |
| MousePheno | abnormal B cell apoptosis | 2.88e-06 | 47 | 30 | 4 | MP:0008781 | |
| MousePheno | abnormal germinal center B cell number | 5.45e-06 | 55 | 30 | 4 | MP:0013680 | |
| MousePheno | abnormal germinal center B cell morphology | 5.45e-06 | 55 | 30 | 4 | MP:0008176 | |
| MousePheno | abnormal class switch recombination | 2.56e-05 | 81 | 30 | 4 | MP:0004816 | |
| MousePheno | abnormal B cell differentiation | 2.79e-05 | 287 | 30 | 6 | MP:0002144 | |
| MousePheno | polycystic kidney | 4.22e-05 | 92 | 30 | 4 | MP:0008528 | |
| MousePheno | abnormal cyst | 3.68e-04 | 294 | 30 | 5 | MP:0031310 | |
| MousePheno | abnormal lymphocyte cell number | KMT2A FAM72D ZNF91 MDM2 FAM72C ZNF99 ABCE1 FAM72B FAM72A LTN1 | 4.26e-04 | 1390 | 30 | 10 | MP:0000717 |
| MousePheno | increased mature B cell number | 4.32e-04 | 168 | 30 | 4 | MP:0008210 | |
| MousePheno | abnormal lymphopoiesis | 5.21e-04 | 490 | 30 | 6 | MP:0002401 | |
| MousePheno | kidney cyst | 5.26e-04 | 177 | 30 | 4 | MP:0003675 | |
| MousePheno | abnormal lymphocyte morphology | KMT2A FAM72D ZNF91 MDM2 FAM72C ZNF99 ABCE1 FAM72B FAM72A LTN1 | 7.16e-04 | 1483 | 30 | 10 | MP:0002619 |
| MousePheno | abnormal B cell number | 7.58e-04 | 526 | 30 | 6 | MP:0002458 | |
| Domain | FAM72 | 1.62e-11 | 4 | 39 | 4 | PF14976 | |
| Domain | FAM72 | 1.62e-11 | 4 | 39 | 4 | IPR026768 | |
| Domain | - | RNF144B RNF151 KMT2A PHF7 G2E3 SPIRE2 RPH3AL MDM2 UBE4B RNF212 LTN1 | 1.25e-09 | 449 | 39 | 11 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | RNF144B RNF151 KMT2A PHF7 G2E3 SPIRE2 RPH3AL MDM2 UBE4B RNF212 LTN1 | 1.58e-09 | 459 | 39 | 11 | IPR013083 |
| Domain | KRAB | 6.17e-07 | 358 | 39 | 8 | PS50805 | |
| Domain | KRAB | 6.17e-07 | 358 | 39 | 8 | PF01352 | |
| Domain | KRAB | 7.75e-07 | 369 | 39 | 8 | SM00349 | |
| Domain | KRAB | 7.91e-07 | 370 | 39 | 8 | IPR001909 | |
| Domain | RING | 2.84e-06 | 305 | 39 | 7 | SM00184 | |
| Domain | zf-C2H2_6 | 3.44e-06 | 314 | 39 | 7 | PF13912 | |
| Domain | Znf_RING | 4.41e-06 | 326 | 39 | 7 | IPR001841 | |
| Domain | - | 8.38e-06 | 679 | 39 | 9 | 3.30.160.60 | |
| Domain | zf-C2H2 | 9.87e-06 | 693 | 39 | 9 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 9.98e-06 | 694 | 39 | 9 | IPR013087 | |
| Domain | EPHD | 1.26e-05 | 22 | 39 | 3 | PS51805 | |
| Domain | Znf_FYVE_PHD | 1.31e-05 | 147 | 39 | 5 | IPR011011 | |
| Domain | ZINC_FINGER_C2H2_2 | 2.40e-05 | 775 | 39 | 9 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 2.45e-05 | 777 | 39 | 9 | PS00028 | |
| Domain | ZF_RING_1 | 2.88e-05 | 291 | 39 | 6 | PS00518 | |
| Domain | Znf_C2H2-like | 2.97e-05 | 796 | 39 | 9 | IPR015880 | |
| Domain | Znf_C2H2 | 3.24e-05 | 805 | 39 | 9 | IPR007087 | |
| Domain | ZF_RING_2 | 3.29e-05 | 298 | 39 | 6 | PS50089 | |
| Domain | ZnF_C2H2 | 3.34e-05 | 808 | 39 | 9 | SM00355 | |
| Domain | U-box | 1.18e-04 | 8 | 39 | 2 | PF04564 | |
| Domain | Ubox_domain | 1.89e-04 | 10 | 39 | 2 | IPR003613 | |
| Domain | zf-CXXC | 2.31e-04 | 11 | 39 | 2 | PF02008 | |
| Domain | Znf_CXXC | 2.31e-04 | 11 | 39 | 2 | IPR002857 | |
| Domain | ZF_CXXC | 2.31e-04 | 11 | 39 | 2 | PS51058 | |
| Domain | PHD | 8.44e-04 | 89 | 39 | 3 | SM00249 | |
| Domain | Znf_PHD | 9.01e-04 | 91 | 39 | 3 | IPR001965 | |
| Domain | Beta_defensin | 9.56e-04 | 22 | 39 | 2 | IPR025933 | |
| Domain | Defensin_beta_2 | 9.56e-04 | 22 | 39 | 2 | PF13841 | |
| Domain | ZF_PHD_2 | 1.02e-03 | 95 | 39 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 1.05e-03 | 96 | 39 | 3 | PS01359 | |
| Domain | SET | 3.31e-03 | 41 | 39 | 2 | PF00856 | |
| Domain | SET | 4.15e-03 | 46 | 39 | 2 | SM00317 | |
| Domain | Znf_RING_CS | 4.74e-03 | 163 | 39 | 3 | IPR017907 | |
| Domain | SET_dom | 4.89e-03 | 50 | 39 | 2 | IPR001214 | |
| Domain | SET | 4.89e-03 | 50 | 39 | 2 | PS50280 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | KMT2A ZNF430 ZFP90 GRIN2A ZNF100 ZNF230 MDM2 ZNF99 ZNF726 ZNF730 | 9.99e-05 | 1387 | 26 | 10 | M734 |
| Pubmed | Fam72a enforces error-prone DNA repair during antibody diversification. | 1.35e-12 | 4 | 39 | 4 | 34819671 | |
| Pubmed | Identification and characterisation of the novel amyloid-beta peptide-induced protein p17. | 6.74e-12 | 5 | 39 | 4 | 19755123 | |
| Pubmed | 6.74e-12 | 5 | 39 | 4 | 26206078 | ||
| Pubmed | FAM72A antagonizes UNG2 to promote mutagenic repair during antibody maturation. | 2.02e-11 | 6 | 39 | 4 | 34819670 | |
| Pubmed | 1.83e-09 | 15 | 39 | 4 | 1741163 | ||
| Pubmed | 5.88e-07 | 15 | 39 | 3 | 15885501 | ||
| Pubmed | 7.23e-07 | 16 | 39 | 3 | 8467795 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 24587254 | ||
| Pubmed | UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation. | 3.67e-06 | 3 | 39 | 2 | 26673821 | |
| Pubmed | 4.67e-06 | 29 | 39 | 3 | 14563677 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 36865087 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 35996826 | ||
| Pubmed | UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53. | 7.34e-06 | 4 | 39 | 2 | 21317885 | |
| Pubmed | Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemia. | 1.22e-05 | 5 | 39 | 2 | 31337857 | |
| Pubmed | CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. | 1.83e-05 | 6 | 39 | 2 | 19805293 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 12620395 | ||
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 2.32e-05 | 49 | 39 | 3 | 9630514 | |
| Pubmed | 2.50e-05 | 151 | 39 | 4 | 17043677 | ||
| Pubmed | Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation. | 2.56e-05 | 7 | 39 | 2 | 29997176 | |
| Pubmed | 4.39e-05 | 9 | 39 | 2 | 30244831 | ||
| Pubmed | 5.06e-05 | 181 | 39 | 4 | 37372979 | ||
| Pubmed | DNA Sequence Recognition of Human CXXC Domains and Their Structural Determinants. | 5.48e-05 | 10 | 39 | 2 | 29276034 | |
| Pubmed | Functional analysis of the SRY-KRAB interaction in mouse sex determination. | 5.48e-05 | 10 | 39 | 2 | 18588511 | |
| Pubmed | Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein. | 6.70e-05 | 11 | 39 | 2 | 15469996 | |
| Pubmed | 9.48e-05 | 13 | 39 | 2 | 19850934 | ||
| Pubmed | 2.30e-04 | 20 | 39 | 2 | 2542606 | ||
| Pubmed | 2.30e-04 | 20 | 39 | 2 | 7479878 | ||
| Pubmed | Expanding the substantial interactome of NEMO using protein microarrays. | 2.52e-04 | 109 | 39 | 3 | 20098747 | |
| Pubmed | A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system. | 3.18e-04 | 118 | 39 | 3 | 19690564 | |
| Pubmed | 7.12e-04 | 35 | 39 | 2 | 16033865 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 7.32e-04 | 157 | 39 | 3 | 30686591 | |
| Pubmed | Discovery of five conserved beta -defensin gene clusters using a computational search strategy. | 7.96e-04 | 37 | 39 | 2 | 11854508 | |
| Cytoband | 19p12 | 1.48e-10 | 90 | 39 | 6 | 19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 9.44e-10 | 122 | 39 | 6 | chr19p12 | |
| Cytoband | 20p13 | 3.43e-03 | 102 | 39 | 2 | 20p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20p13 | 4.94e-03 | 123 | 39 | 2 | chr20p13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.14e-06 | 718 | 29 | 9 | 28 | |
| GeneFamily | Zinc fingers CXXC-type | 1.62e-04 | 12 | 29 | 2 | 136 | |
| GeneFamily | PHD finger proteins | 3.97e-04 | 90 | 29 | 3 | 88 | |
| GeneFamily | Ring finger proteins | 9.22e-04 | 275 | 29 | 4 | 58 | |
| GeneFamily | Defensins, beta | 2.57e-03 | 47 | 29 | 2 | 503 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-08 | 199 | 39 | 6 | c6d59ed26eadd3c41acfe1b4d929270e00ea3e95 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 5.42e-07 | 183 | 39 | 5 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 8.00e-07 | 198 | 39 | 5 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 8.00e-07 | 198 | 39 | 5 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 8.20e-07 | 199 | 39 | 5 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.20e-07 | 199 | 39 | 5 | c9d15c84b9f8c87b4ea0008be7d5efc5f45efd1a | |
| ToppCell | (1)_T_cell-(18)_cycling_gd_T|(1)_T_cell / shred on Cell_type and subtype | 8.20e-07 | 199 | 39 | 5 | 9369d0e4efe809e3e8757294ebebba5a47b30528 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-6|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.04e-05 | 156 | 39 | 4 | d249747c7108a0edfc72d24c09b0b0e4ed662b40 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.30e-05 | 191 | 39 | 4 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.35e-05 | 192 | 39 | 4 | 026f3e38970bea1e6e8d76a4e2becdfb8484b2ff | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.35e-05 | 192 | 39 | 4 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.45e-05 | 194 | 39 | 4 | 06b8dc2e46f833707d5b68b324b4ff6c4d0dccf9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.50e-05 | 195 | 39 | 4 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.50e-05 | 195 | 39 | 4 | 742c82c86487314cdb3178012004adb1164bcbdb | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | 2.71e-05 | 199 | 39 | 4 | 72823f26ecabcae1b514b7629cfce010c97b929a | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 2.71e-05 | 199 | 39 | 4 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 2.71e-05 | 199 | 39 | 4 | d8f904f531bfe091b7d8caaa147ea4a03d627995 | |
| ToppCell | Caecum-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 2.71e-05 | 199 | 39 | 4 | 64d1e495307a91bc012130613126d86e0cf170b0 | |
| ToppCell | (18)_cycling_gd_T|World / shred on Cell_type and subtype | 2.92e-05 | 203 | 39 | 4 | 7d58929058c4769226a29febee1fd8ba64bc9f1a | |
| Disease | bipolar disorder (is_implicated_in) | 5.44e-04 | 29 | 35 | 2 | DOID:3312 (is_implicated_in) | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 2.63e-03 | 64 | 35 | 2 | DOID:224 (implicated_via_orthology) | |
| Disease | age at initiation of smoking | 2.80e-03 | 66 | 35 | 2 | EFO_0021784 | |
| Disease | schizophrenia (is_implicated_in) | 3.88e-03 | 78 | 35 | 2 | DOID:5419 (is_implicated_in) | |
| Disease | Depression, Bipolar | 3.98e-03 | 79 | 35 | 2 | C0005587 | |
| Disease | Tinnitus, wellbeing measurement | 5.81e-03 | 96 | 35 | 2 | EFO_0007869, HP_0000360 | |
| Disease | response to antineoplastic agent | 6.17e-03 | 99 | 35 | 2 | GO_0097327 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 6.41e-03 | 101 | 35 | 2 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | trait in response to apixaban | 8.24e-03 | 115 | 35 | 2 | OBA_2050328 | |
| Disease | Adenocarcinoma | 8.38e-03 | 116 | 35 | 2 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 8.38e-03 | 116 | 35 | 2 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 8.38e-03 | 116 | 35 | 2 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 8.38e-03 | 116 | 35 | 2 | C0205642 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LCCLYRLCKKSKPIK | 691 | Q9UKF5 | |
| PCPCKCKTKRQKNML | 421 | Q86SJ2 | |
| QLKEKKKKGYCECCL | 286 | Q9UBU7 | |
| KNKLCSCKCPLLGKV | 676 | Q9NRI5 | |
| PKKKLICSVCNKKCS | 291 | Q9NQX1 | |
| NYSLPKKACRTCKKK | 1726 | O94822 | |
| CVCKSCRGKKKKHDP | 286 | Q7Z419 | |
| FTKICKCKLKDIACL | 61 | Q6L9T8 | |
| KCKLKDIACLKCGNI | 66 | Q6L9T8 | |
| VICCCKRQKGKPKRK | 951 | Q8IZA0 | |
| FTKICKCKLKDIACL | 61 | Q5TYM5 | |
| KCKLKDIACLKCGNI | 66 | Q5TYM5 | |
| KSCLQGACQKPRKKK | 166 | C9JSJ3 | |
| CKFRKCEELKKKPSA | 291 | Q7LFL8 | |
| KEVNRASKLKCCVCK | 71 | Q7L622 | |
| CKPKKCRQECKKSCP | 16 | P61221 | |
| QKCKMKKCCVGPKVV | 46 | Q9H1M3 | |
| FTKICKCKLKDIACL | 61 | H0Y354 | |
| KCKLKDIACLKCGNI | 66 | H0Y354 | |
| KKKVWICTKCVRCKS | 1521 | Q03164 | |
| VCKAGKKKKNCFLCA | 26 | Q9NV70 | |
| KCLNDVGICKKKCKP | 26 | Q9BYW3 | |
| FTKICKCKLKDIACL | 61 | Q86X60 | |
| KCKLKDIACLKCGNI | 66 | Q86X60 | |
| FCKDCRKKVCTKCGI | 111 | Q9UNE2 | |
| CFCICKKCLFKKKNK | 76 | P21579 | |
| QKTCPCCRKEVKRKK | 51 | Q2KHN1 | |
| KICFVCKKKGAAINC | 96 | Q9BWX1 | |
| CFTCAKKLKKRNKPC | 461 | Q00987 | |
| KGKKNECLICKAPCR | 36 | Q495C1 | |
| KCKIIHTGKKPCKCE | 246 | A8MXY4 | |
| RKKPFKCKKCEKSFC | 201 | Q8IYN0 | |
| LKNCPSVALKKKAKC | 56 | Q8N8B7 | |
| LKKGKICCCCRAKFP | 566 | Q8WWL2 | |
| CKTQLKKLVRCKACA | 816 | O95155 | |
| KPFKCKECGKLFCIL | 171 | Q6ZMV8 | |
| RHTRKKPFKCKNCVK | 166 | A6NNF4 | |
| GKKPFKCKKCDKSFC | 201 | Q9H8G1 | |
| CFKCKKCVKSFCIRL | 181 | Q05481 | |
| KKLHCRKKPFKCEDC | 411 | Q9UIE0 | |
| KCCLFCFRKLAKTGK | 511 | O75795 | |
| AKKKPYKCDKCRKAF | 206 | Q8TF47 | |
| NVKKCCKGFCIDILK | 451 | Q12879 |